Detalles de la búsqueda
1.
Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia.
Pharmacol Biochem Behav
; 91(1): 47-58, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18621075
2.
SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.
Neuropsychopharmacology
; 32(1): 17-34, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16936709
3.
SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile.
Neuropsychopharmacology
; 32(1): 1-16, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17019409
4.
Utility of a Mouse Model of Osteoarthritis to Demonstrate Cartilage Protection by IFNγ-Primed Equine Mesenchymal Stem Cells.
Front Immunol
; 7: 392, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27729913
5.
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
Neuropsychopharmacology
; 30(11): 1963-85, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15956994
6.
Development of an equine groove model to induce metacarpophalangeal osteoarthritis: a pilot study on 6 horses.
PLoS One
; 10(2): e0115089, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25680102
7.
The vasopressin V1b receptor as a therapeutic target in stress-related disorders.
Curr Drug Targets CNS Neurol Disord
; 2(3): 191-200, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12769799
8.
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.
Neuropsychopharmacology
; 28(12): 2064-76, 2003 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12902994
9.
The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Naunyn Schmiedebergs Arch Pharmacol
; 365(6): 427-33, 2002 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12070755
10.
Specific involvement of neurotensin type 1 receptor in the neurotensin-mediated in vivo dopamine efflux using knock-out mice.
J Neurochem
; 89(1): 1-6, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15030383
11.
Permissive role of neurokinin NK(3) receptors in NK(1) receptor-mediated activation of the locus coeruleus revealed by SR 142801.
Synapse
; 43(1): 62-9, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11746734
12.
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders.
J Pharmacol Exp Ther
; 301(1): 333-45, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11907191
13.
Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist.
Can J Physiol Pharmacol
; 80(5): 482-8, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12056557
14.
SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
J Pharmacol Exp Ther
; 303(3): 1171-9, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12438541
15.
SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin 1 receptor: II. Neurochemical and behavioral characterization.
J Pharmacol Exp Ther
; 303(3): 1180-8, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12438542
16.
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization.
J Pharmacol Exp Ther
; 301(1): 322-32, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11907190
Resultados
1 -
16
de 16
1
Próxima >
>>